Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Luis Gabriel Cuervo, clinical editor BMJ Knowledge (lgcuervo@bmjgroup.com),
  2. Jeffrey K Aronson, reader in clinical pharmacology (jeffrey.aronson@clinpharm.ox.ac.uk)
  1. BMA House, London WC1H 9JR
  2. University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE

    Balancing benefits and harms of interventions is essential

    “There are some patients that we cannot help; there are none whom we cannot harm.”

    Attributed to Arthur L Bloomfield

    Before you next get into your car or walk out into the street, reflect that the number of deaths from road crashes in the United Kingdom is about 3400 a year.1 Elsewhere in the world the rates are up to six times higher.2 Now compare that with the extrapolated figure for the United Kingdom of more than twice that number of deaths each year from adverse drug reactions, estimated from the results of a prospective study published in this theme issue of the BMJ.3 Now try to estimate the benefit to harm balance of a road trip and the benefit to harm balance of a drug that you have recently used.

    But drugs are far from being the only interventions we use in health care; even when drugs are prescribed they are often only part of an overall plan of care. Other interventions include lifestyle …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL